Proteomics Archives | EMBL
Melting reveals drug targets in a living organism
EMBL scientists identify drug targets in blood and organs
Decoding ageing
The naked mole-rat as a model organism in ageing research
ATP affects proteome-wide solubility
Scientists develop technology to measure how ATP concentration affects protein solubility in cells
Melting bacteria to decipher antibiotic resistance
EMBL scientists investigate how bacteria melt to study their reaction to drugs
Futures: The dark proteome
ERC grantee Edward Lemke shares his vision for the next ten years
Futures: Brain evolution
ERC grantee Detlev Arendt shares his vision for the next ten years
Turning up the heat on drug side effects
Side-effects of leukaemia drug explained, reveal possibility of repurposing to treat other diseases
Welcome to EMBL: Mikhail Savitski
New head of Proteomics Core Facility also runs stability proteomics lab
Powering proteomics progress
EMBL alumnus Angus Lamond is driving forward new ways to explore the proteome
Christian Boulin Fellowship
New Christian Boulin Fellowship: 15 awards of up to €1500 for visitors to EMBL’s Core Facilities.
